caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710988746

Robert Golden

UrologySpokane, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Robert Golden's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 29 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PROVIDENCE HEALTH & SERVICES - WA85248
Incyte Pathology, P.S.
Clinical Laboratory · Spokane Valley, WA
83142
Bruce Britton
Pathology · Spokane Valley, WA
47124
Randi Hart
Diagnostic Radiology · Lynnwood, WA
3169
MULTICARE HEALTH SYSTEM2951
PROVIDENCE HEALTH & SERVICES - WASHINGTON2359
Madison Mcculloch
Diagnostic Radiology · Eden Prairie, MN
2344
David Fischer
Internal Medicine · Spokane Valley, WA
2189
Brian Yates
Internal Medicine · Spokane Valley, WA
20104
Anthony Mueller
Emergency Medicine · Spokane, WA
1870
Daniel Fullmer
Diagnostic Radiology · Lynnwood, WA
1727
Kristopher Stanton
Family Practice · Spokane, WA
1741
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
101
Beneficiaries
—
Total drug cost
$9K
Distinct drugs
3
Brand share
13.9%
Top prescribed drugs
Tamsulosin Hcl73 claims
Finasteride14 claims
Mirabegron14 claims
QUALITY · MIPS · 2024
Final MIPS score
55.4
Quality
22.7
Cost
78.6
Improvement activities
0.0
Promoting interop.
100.0
Payment adjustment
-2.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.